/LOBE.CN
LOBE.CN Stock - Lobe Sciences Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericCNQ
$0.04-22.22%
$0.01 (-22.22%) • Dec 22
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.23
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.04
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LOBE.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.03 – $0.04
TARGET (TP)$0.04
STOP LOSS$0.03
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.20
52W High$0.08
52W Low$0.02
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $136,205 | $840,534 | N/A | N/A | $884,837 |
| Gross Profit | $134,446 | $772,826 | $-10,222 | N/A | $884,837 |
| Gross Margin | 98.7% | 91.9% | N/A | N/A | 100.0% |
| Operating Income | $-2,116,000 | $-3,359,000 | $-4,113,000 | $-6,375,000 | $-2,708,000 |
| Net Income | $-4,421,000 | $-4,707,000 | $-12,253,000 | $-22,821,000 | $-3,436,000 |
| Net Margin | -3245.8% | -560.0% | N/A | N/A | -388.3% |
| EPS | $-0.04 | $-0.05 | $-0.32 | $-0.70 | $-0.27 |
Company Overview
Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LOBE.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2025
EPS Surprise History
Q3 23
No data
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2026 | Dec 28, 2026 | — | — | — | — |
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Jan 26, 2026 | — | — | — | — |
Q2 2025 | Apr 28, 2025 | — | $-0.00 | — | — |
Q1 2025 | Feb 13, 2025 | — | $-0.00 | — | — |
Q1 2025 | Jan 28, 2025 | — | $-0.02 | — | — |
Q3 2024 | Jul 26, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 29, 2024 | — | $-0.01 | — | — |
Q1 2024 | Feb 20, 2024 | — | $-0.01 | — | — |
Q3 2023 | Sep 11, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 1, 2023 | — | $-0.00 | — | — |
Q2 2023 | Apr 28, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 30, 2023 | — | $-0.03 | — | — |
Q4 2022 | Dec 22, 2022 | — | $-0.41 | — | — |
Q3 2022 | Jul 20, 2022 | — | $-0.08 | — | — |
Q2 2022 | May 31, 2022 | — | $-0.31 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.12 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.49 | — | — |
Q2 2021 | May 31, 2021 | — | $1.94 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.09 | — | — |
Latest News
Loading news...
Frequently Asked Questions about LOBE.CN
What is LOBE.CN's current stock price?
Lobe Sciences Ltd. (LOBE.CN) is currently trading at $0.04 per share. The stock has moved -22.22% today.
What is the analyst price target for LOBE.CN?
No analyst price targets are currently available for this stock.
What sector is Lobe Sciences Ltd. in?
Lobe Sciences Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.
What is LOBE.CN's market cap?
Lobe Sciences Ltd. has a market capitalization of $0.01 billion, making it a small-cap company.
Does LOBE.CN pay dividends?
No, Lobe Sciences Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAIML.CN
AI/ML Innovations Inc.
$0.04
Mkt Cap: $0.0B
AVNT.TO
Avant Brands Inc.
$0.98
Mkt Cap: $0.0B
AYUR.CN
Ayurcann Holdings Corp.
$0.03
Mkt Cap: $0.0B
BBM.CN
Blueberries Medical Corp.
$0.01
Mkt Cap: $0.0B
CLSH.CN
CLS Holdings USA, Inc.
$0.04
Mkt Cap: $0.0B
CTX.TO
Crescita Therapeutics Inc.
$0.45
Mkt Cap: $0.0B
DHB.V
Delivra Health Brands Inc.
$0.24
Mkt Cap: $0.0B
MYCO.NE
Mydecine Innovations Group Inc.
$0.18
Mkt Cap: $0.0B
OILS.CN
Nextleaf Solutions Ltd.
$0.06
Mkt Cap: $0.0B
PWR.CN
Captiva Verde Wellness Corp.
$0.04
Mkt Cap: $0.0B
Explore stocks similar to LOBE.CN for comparison